These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6285153

  • 1. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A, Baraghini F, Barbieri C, Dalla Vecchia E, Previdi AM, Di Renzo GC, Volpe A.
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [Abstract] [Full Text] [Related]

  • 2. An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia.
    Volpe A, Botticelli A, Abrate M, Dalla Vecchia E, Mantovani M, Carani C, Grasso A, Mazza V, Di Renzo GC.
    Maturitas; 1982 Apr; 4(1):73-9. PubMed ID: 6285154
    [Abstract] [Full Text] [Related]

  • 3. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S.
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [Abstract] [Full Text] [Related]

  • 4. The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.
    Kemeter P, Bernaschek G, Altmann G, Feichtinger W.
    Arch Gynecol; 1984 Oct; 234(3):219-29. PubMed ID: 6428330
    [Abstract] [Full Text] [Related]

  • 5. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
    Keller PJ, Riedmann R, Fischer M, Gerber C.
    Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
    [Abstract] [Full Text] [Related]

  • 6. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L, Naessén T, Eriksson K, Rune C.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [Abstract] [Full Text] [Related]

  • 7. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M, Carlström K.
    Acta Obstet Gynecol Scand; 1977 Jun; 56(4):351-61. PubMed ID: 602703
    [Abstract] [Full Text] [Related]

  • 8. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
    Castelo-Branco C, Palacios S, Martinez de Osaba MJ, Balasch J, Fortuny A, Vanrell J.
    Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
    [Abstract] [Full Text] [Related]

  • 9. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S, Collins WP, Thom MH, Studd JW.
    Br Med J; 1979 Apr 14; 1(6169):983-5. PubMed ID: 219937
    [Abstract] [Full Text] [Related]

  • 10. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D, Nilsson S.
    Maturitas; 1984 Apr 14; 5(4):233-43. PubMed ID: 6429481
    [Abstract] [Full Text] [Related]

  • 11. [Serum hormone level and Kupperman menopausal complaints in sexually mature women with disturbance of ovulation].
    Kano T, Nishikawa K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan 14; 37(1):31-7. PubMed ID: 3919122
    [Abstract] [Full Text] [Related]

  • 12. The significance of oestriol in the management of the post-menopause.
    Tzingounis VA, Aksu MF, Greenblatt RB.
    Acta Endocrinol Suppl (Copenh); 1980 Jan 14; 233():45-50. PubMed ID: 6773286
    [Abstract] [Full Text] [Related]

  • 13. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M, Franchi F, Argenio GF, Barletta D, Romano MR, Bernini GP, Gasperi M, Sgrilli R.
    Int J Tissue React; 1981 Jun 14; 3(2):77-81. PubMed ID: 6799393
    [Abstract] [Full Text] [Related]

  • 14. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
    Lind T, Cameron EH, Hunter WM.
    Br J Obstet Gynaecol; 1978 Feb 14; 85(2):138-41. PubMed ID: 626723
    [Abstract] [Full Text] [Related]

  • 15. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens.
    Vasquez JM, Samaras CA, Nezhat C.
    Reproduccion; 1982 Feb 14; 6(2):49-59. PubMed ID: 6216132
    [Abstract] [Full Text] [Related]

  • 16. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J, Ulm R, Bieglmayer C, Husslein P.
    Gynecol Obstet Invest; 1979 Feb 14; 10(2-3):71-80. PubMed ID: 535775
    [Abstract] [Full Text] [Related]

  • 17. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.
    Am J Obstet Gynecol; 1995 Jan 14; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [Abstract] [Full Text] [Related]

  • 18. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A, Facchinetti F, Grasso A, Petraglia F, Campanini D, Genazzani AR.
    Maturitas; 1986 Dec 14; 8(4):327-34. PubMed ID: 3033444
    [Abstract] [Full Text] [Related]

  • 19. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
    Mattsson LA, Abrahamsson L, Cullberg G, Samsioe G.
    Arch Gynecol; 1983 Dec 14; 233(2):101-7. PubMed ID: 6683955
    [Abstract] [Full Text] [Related]

  • 20. Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments.
    Rauramo L, Punnonen R, Grönroos M.
    Maturitas; 1981 Aug 14; 3(2):183-6. PubMed ID: 7289888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.